Waldencast PLC (NASDAQ:WALD) Receives $4.42 Consensus Price Target from Analysts

Shares of Waldencast PLC (NASDAQ:WALD) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $4.4167.

Several research firms have recently weighed in on WALD. Canaccord Genuity Group lowered their price objective on shares of Waldencast from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Tuesday, November 25th. Jefferies Financial Group began coverage on shares of Waldencast in a research note on Wednesday, January 14th. They issued a “buy” rating and a $2.00 price target for the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Waldencast in a research report on Wednesday, January 21st. Finally, Telsey Advisory Group downgraded Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 price objective for the company. in a report on Tuesday, November 25th.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its holdings in shares of Waldencast by 12.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,702 shares of the company’s stock worth $114,000 after acquiring an additional 6,516 shares during the last quarter. Geode Capital Management LLC increased its holdings in Waldencast by 62.2% during the 2nd quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock worth $1,437,000 after purchasing an additional 224,905 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Waldencast by 15.2% in the first quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock worth $185,000 after purchasing an additional 8,151 shares during the last quarter. Squarepoint Ops LLC purchased a new stake in shares of Waldencast in the third quarter worth approximately $78,000. Finally, Jane Street Group LLC bought a new position in shares of Waldencast in the first quarter valued at approximately $77,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Waldencast Stock Down 0.6%

Shares of NASDAQ:WALD opened at $1.80 on Monday. Waldencast has a 1 year low of $1.45 and a 1 year high of $3.54. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 0.67. The business’s 50-day moving average is $1.78 and its 200-day moving average is $1.89.

Waldencast (NASDAQ:WALD) last issued its earnings results on Monday, November 24th. The company reported ($0.69) earnings per share for the quarter. The business had revenue of $66.14 million during the quarter. On average, research analysts anticipate that Waldencast will post -0.14 EPS for the current fiscal year.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.